139 related articles for article (PubMed ID: 18456462)
1. Proteomic analysis of miltefosine-resistant Leishmania reveals the possible involvement of eukaryotic initiation factor 4A (eIF4A).
Singh G; Chavan HD; Dey CS
Int J Antimicrob Agents; 2008 Jun; 31(6):584-6. PubMed ID: 18456462
[No Abstract] [Full Text] [Related]
2. Miltefosine induces apoptosis in arsenite-resistant Leishmania donovani promastigotes through mitochondrial dysfunction.
Verma NK; Singh G; Dey CS
Exp Parasitol; 2007 May; 116(1):1-13. PubMed ID: 17161839
[TBL] [Abstract][Full Text] [Related]
3. Miltefosine--discovery of the antileishmanial activity of phospholipid derivatives.
Croft SL; Engel J
Trans R Soc Trop Med Hyg; 2006 Dec; 100 Suppl 1():S4-8. PubMed ID: 16904717
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical use.
Pérez-Victoria FJ; Sánchez-Cañete MP; Seifert K; Croft SL; Sundar S; Castanys S; Gamarro F
Drug Resist Updat; 2006; 9(1-2):26-39. PubMed ID: 16814199
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo.
Seifert K; Pérez-Victoria FJ; Stettler M; Sánchez-Cañete MP; Castanys S; Gamarro F; Croft SL
Int J Antimicrob Agents; 2007 Sep; 30(3):229-35. PubMed ID: 17628445
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of 16-mercaptohexadecylphosphocholine, a miltefosine analog with leishmanicidal activity.
Hornillos V; Saugar JM; de la Torre BG; Andreu D; Rivas L; Acuña AU; Amat-Guerri F
Bioorg Med Chem Lett; 2006 Oct; 16(19):5190-3. PubMed ID: 16870434
[TBL] [Abstract][Full Text] [Related]
7. In Vitro and In Vivo Miltefosine Susceptibility of a Leishmania amazonensis Isolate from a Patient with Diffuse Cutaneous Leishmaniasis: Follow-Up.
Coelho AC; Trinconi CT; Costa CH; Uliana SR
PLoS Negl Trop Dis; 2016 Jul; 10(7):e0004720. PubMed ID: 27416021
[No Abstract] [Full Text] [Related]
8. (Post-) Genomic approaches to tackle drug resistance in Leishmania.
Berg M; Mannaert A; Vanaerschot M; Van Der Auwera G; Dujardin JC
Parasitology; 2013 Oct; 140(12):1492-505. PubMed ID: 23480865
[TBL] [Abstract][Full Text] [Related]
9. Effect of the lysophospholipid analogues edelfosine, ilmofosine and miltefosine against Leishmania amazonensis.
Santa-Rita RM; Henriques-Pons A; Barbosa HS; de Castro SL
J Antimicrob Chemother; 2004 Oct; 54(4):704-10. PubMed ID: 15329361
[TBL] [Abstract][Full Text] [Related]
10. Gene amplification in amphotericin B-resistant Leishmania tarentolae.
Singh AK; Papadopoulou B; Ouellette M
Exp Parasitol; 2001 Nov; 99(3):141-7. PubMed ID: 11846524
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of perifosine: a novel alkylphospholipid against the promastigote stage of Leishmania species.
Cabrera-Serra MG; Lorenzo-Morales J; Romero M; Valladares B; Piñero JE
Parasitol Res; 2007 Apr; 100(5):1155-7. PubMed ID: 17206506
[TBL] [Abstract][Full Text] [Related]
12. Mucosal leishmaniasis and miltefosine.
Tuon FF; Amato VS
Clin Infect Dis; 2007 Jun; 44(11):1525-6; author reply 1526-7. PubMed ID: 17479959
[No Abstract] [Full Text] [Related]
13. Leishmaniasis.
Desjeux P
Nat Rev Microbiol; 2004 Sep; 2(9):692. PubMed ID: 15378809
[No Abstract] [Full Text] [Related]
14. Down regulation of KMP-11 in Leishmania infantum axenic antimony resistant amastigotes as revealed by a proteomic screen.
El Fadili K; Drummelsmith J; Roy G; Jardim A; Ouellette M
Exp Parasitol; 2009 Sep; 123(1):51-7. PubMed ID: 19500579
[TBL] [Abstract][Full Text] [Related]
15. Antileishmanial and antifungal activities of xanthanolides isolated from Xanthium macrocarpum.
Lavault M; Landreau A; Larcher G; Bouchara JP; Pagniez F; Le Pape P; Richomme P
Fitoterapia; 2005 Jun; 76(3-4):363-6. PubMed ID: 15890467
[TBL] [Abstract][Full Text] [Related]
16. Miltefosine promotes IFN-gamma-dominated anti-leishmanial immune response.
Wadhone P; Maiti M; Agarwal R; Kamat V; Martin S; Saha B
J Immunol; 2009 Jun; 182(11):7146-54. PubMed ID: 19454711
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of BODIPY-labeled alkylphosphocholines with leishmanicidal activity, as fluorescent analogues of miltefosine.
Hornillos V; Carrillo E; Rivas L; Amat-Guerri F; Acuña AU
Bioorg Med Chem Lett; 2008 Dec; 18(24):6336-9. PubMed ID: 18990566
[TBL] [Abstract][Full Text] [Related]
18. Modulation in aquaglyceroporin AQP1 gene transcript levels in drug-resistant Leishmania.
Marquis N; Gourbal B; Rosen BP; Mukhopadhyay R; Ouellette M
Mol Microbiol; 2005 Sep; 57(6):1690-9. PubMed ID: 16135234
[TBL] [Abstract][Full Text] [Related]
19. Genetics. Leishmania exploit sex.
Miles MA; Yeo M; Mauricio IL
Science; 2009 Apr; 324(5924):187-9. PubMed ID: 19359570
[No Abstract] [Full Text] [Related]
20. Leishmania spp.: proficiency of drug-resistant parasites.
Natera S; Machuca C; Padrón-Nieves M; Romero A; Díaz E; Ponte-Sucre A
Int J Antimicrob Agents; 2007 Jun; 29(6):637-42. PubMed ID: 17353113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
